 | • レポートコード：QFJ1-4289 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、難聴療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外耳＆中耳装置、骨固定補聴器、人工内耳＆ハイブリッド、聴覚脳幹インプラント、その他）、用途別市場規模（病院、耳科クリニック、外来クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・難聴療法の市場動向 ・企業の競争状況、市場シェア ・難聴療法の種類別市場規模と予測2016-2027（外耳＆中耳装置、骨固定補聴器、人工内耳＆ハイブリッド、聴覚脳幹インプラント、その他） ・難聴療法の用途別市場規模と予測2016-2027（病院、耳科クリニック、外来クリニック、その他） ・難聴療法の北米市場規模2016-2027（アメリカ、カナダ） ・難聴療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・難聴療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・難聴療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・難聴療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Widex、MED-EL、Cochlear、Smith & Nephew、Pfizer、Bristol-Myers Squibb Company、Allergan、Renate pharmaceutical、Merck、F. Hoffmann-La Roche、Eli Lilly and Company、Novartis、GlaxoSmithKline、Teva pharmaceuticals、Audina Hearing Instruments） ・結論 |
Hearing loss therapy refers to the latest technological advances and treatment options for people with hearing impairment, including external and middle ear devices, bone anchors, cochlear implants and mixed arteries, auditory brainstem implants, and the transfer of genes to the inner ear through stem cell therapy and hair cell regeneration for the treatment of sensorineural hearing loss.
Market Analysis and Insights: Global Hearing Loss Therapy Market
The global Hearing Loss Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hearing Loss Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hearing Loss Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hearing Loss Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hearing Loss Therapy market.
Global Hearing Loss Therapy Scope and Market Size
Hearing Loss Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hearing Loss Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
External and Middle Ear Devices
Bone-Anchored Hearing Aids
Cochlear Implants and Hybrids
Auditory Brainstem Implants
Others
Segment by Application
Hospitals
Otology Clinics
Ambulatory Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Widex
MED-EL
Cochlear
Smith & Nephew
Pfizer
Bristol-Myers Squibb Company
Allergan
Renate pharmaceutical
Merck
F. Hoffmann-La Roche
Eli Lilly and Company
Novartis
GlaxoSmithKline
Teva pharmaceuticals
Audina Hearing Instruments
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hearing Loss Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 External and Middle Ear Devices
1.2.3 Bone-Anchored Hearing Aids
1.2.4 Cochlear Implants and Hybrids
1.2.5 Auditory Brainstem Implants
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hearing Loss Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Otology Clinics
1.3.4 Ambulatory Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hearing Loss Therapy Market Perspective (2016-2027)
2.2 Hearing Loss Therapy Growth Trends by Regions
2.2.1 Hearing Loss Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hearing Loss Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Hearing Loss Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Hearing Loss Therapy Industry Dynamic
2.3.1 Hearing Loss Therapy Market Trends
2.3.2 Hearing Loss Therapy Market Drivers
2.3.3 Hearing Loss Therapy Market Challenges
2.3.4 Hearing Loss Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hearing Loss Therapy Players by Revenue
3.1.1 Global Top Hearing Loss Therapy Players by Revenue (2016-2021)
3.1.2 Global Hearing Loss Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Hearing Loss Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hearing Loss Therapy Revenue
3.4 Global Hearing Loss Therapy Market Concentration Ratio
3.4.1 Global Hearing Loss Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hearing Loss Therapy Revenue in 2020
3.5 Hearing Loss Therapy Key Players Head office and Area Served
3.6 Key Players Hearing Loss Therapy Product Solution and Service
3.7 Date of Enter into Hearing Loss Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hearing Loss Therapy Breakdown Data by Type
4.1 Global Hearing Loss Therapy Historic Market Size by Type (2016-2021)
4.2 Global Hearing Loss Therapy Forecasted Market Size by Type (2022-2027)
5 Hearing Loss Therapy Breakdown Data by Application
5.1 Global Hearing Loss Therapy Historic Market Size by Application (2016-2021)
5.2 Global Hearing Loss Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hearing Loss Therapy Market Size (2016-2027)
6.2 North America Hearing Loss Therapy Market Size by Type
6.2.1 North America Hearing Loss Therapy Market Size by Type (2016-2021)
6.2.2 North America Hearing Loss Therapy Market Size by Type (2022-2027)
6.2.3 North America Hearing Loss Therapy Market Size by Type (2016-2027)
6.3 North America Hearing Loss Therapy Market Size by Application
6.3.1 North America Hearing Loss Therapy Market Size by Application (2016-2021)
6.3.2 North America Hearing Loss Therapy Market Size by Application (2022-2027)
6.3.3 North America Hearing Loss Therapy Market Size by Application (2016-2027)
6.4 North America Hearing Loss Therapy Market Size by Country
6.4.1 North America Hearing Loss Therapy Market Size by Country (2016-2021)
6.4.2 North America Hearing Loss Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Hearing Loss Therapy Market Size (2016-2027)
7.2 Europe Hearing Loss Therapy Market Size by Type
7.2.1 Europe Hearing Loss Therapy Market Size by Type (2016-2021)
7.2.2 Europe Hearing Loss Therapy Market Size by Type (2022-2027)
7.2.3 Europe Hearing Loss Therapy Market Size by Type (2016-2027)
7.3 Europe Hearing Loss Therapy Market Size by Application
7.3.1 Europe Hearing Loss Therapy Market Size by Application (2016-2021)
7.3.2 Europe Hearing Loss Therapy Market Size by Application (2022-2027)
7.3.3 Europe Hearing Loss Therapy Market Size by Application (2016-2027)
7.4 Europe Hearing Loss Therapy Market Size by Country
7.4.1 Europe Hearing Loss Therapy Market Size by Country (2016-2021)
7.4.2 Europe Hearing Loss Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hearing Loss Therapy Market Size (2016-2027)
8.2 Asia-Pacific Hearing Loss Therapy Market Size by Type
8.2.1 Asia-Pacific Hearing Loss Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hearing Loss Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hearing Loss Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Hearing Loss Therapy Market Size by Application
8.3.1 Asia-Pacific Hearing Loss Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hearing Loss Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hearing Loss Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Hearing Loss Therapy Market Size by Region
8.4.1 Asia-Pacific Hearing Loss Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hearing Loss Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hearing Loss Therapy Market Size (2016-2027)
9.2 Latin America Hearing Loss Therapy Market Size by Type
9.2.1 Latin America Hearing Loss Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Hearing Loss Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Hearing Loss Therapy Market Size by Type (2016-2027)
9.3 Latin America Hearing Loss Therapy Market Size by Application
9.3.1 Latin America Hearing Loss Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Hearing Loss Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Hearing Loss Therapy Market Size by Application (2016-2027)
9.4 Latin America Hearing Loss Therapy Market Size by Country
9.4.1 Latin America Hearing Loss Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Hearing Loss Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hearing Loss Therapy Market Size (2016-2027)
10.2 Middle East & Africa Hearing Loss Therapy Market Size by Type
10.2.1 Middle East & Africa Hearing Loss Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hearing Loss Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hearing Loss Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Hearing Loss Therapy Market Size by Application
10.3.1 Middle East & Africa Hearing Loss Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hearing Loss Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hearing Loss Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Hearing Loss Therapy Market Size by Country
10.4.1 Middle East & Africa Hearing Loss Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hearing Loss Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Widex
11.1.1 Widex Company Details
11.1.2 Widex Business Overview
11.1.3 Widex Hearing Loss Therapy Introduction
11.1.4 Widex Revenue in Hearing Loss Therapy Business (2016-2021)
11.1.5 Widex Recent Development
11.2 MED-EL
11.2.1 MED-EL Company Details
11.2.2 MED-EL Business Overview
11.2.3 MED-EL Hearing Loss Therapy Introduction
11.2.4 MED-EL Revenue in Hearing Loss Therapy Business (2016-2021)
11.2.5 MED-EL Recent Development
11.3 Cochlear
11.3.1 Cochlear Company Details
11.3.2 Cochlear Business Overview
11.3.3 Cochlear Hearing Loss Therapy Introduction
11.3.4 Cochlear Revenue in Hearing Loss Therapy Business (2016-2021)
11.3.5 Cochlear Recent Development
11.4 Smith & Nephew
11.4.1 Smith & Nephew Company Details
11.4.2 Smith & Nephew Business Overview
11.4.3 Smith & Nephew Hearing Loss Therapy Introduction
11.4.4 Smith & Nephew Revenue in Hearing Loss Therapy Business (2016-2021)
11.4.5 Smith & Nephew Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Hearing Loss Therapy Introduction
11.5.4 Pfizer Revenue in Hearing Loss Therapy Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Details
11.6.2 Bristol-Myers Squibb Company Business Overview
11.6.3 Bristol-Myers Squibb Company Hearing Loss Therapy Introduction
11.6.4 Bristol-Myers Squibb Company Revenue in Hearing Loss Therapy Business (2016-2021)
11.6.5 Bristol-Myers Squibb Company Recent Development
11.7 Allergan
11.7.1 Allergan Company Details
11.7.2 Allergan Business Overview
11.7.3 Allergan Hearing Loss Therapy Introduction
11.7.4 Allergan Revenue in Hearing Loss Therapy Business (2016-2021)
11.7.5 Allergan Recent Development
11.8 Renate pharmaceutical
11.8.1 Renate pharmaceutical Company Details
11.8.2 Renate pharmaceutical Business Overview
11.8.3 Renate pharmaceutical Hearing Loss Therapy Introduction
11.8.4 Renate pharmaceutical Revenue in Hearing Loss Therapy Business (2016-2021)
11.8.5 Renate pharmaceutical Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Hearing Loss Therapy Introduction
11.9.4 Merck Revenue in Hearing Loss Therapy Business (2016-2021)
11.9.5 Merck Recent Development
11.10 F. Hoffmann-La Roche
11.10.1 F. Hoffmann-La Roche Company Details
11.10.2 F. Hoffmann-La Roche Business Overview
11.10.3 F. Hoffmann-La Roche Hearing Loss Therapy Introduction
11.10.4 F. Hoffmann-La Roche Revenue in Hearing Loss Therapy Business (2016-2021)
11.10.5 F. Hoffmann-La Roche Recent Development
11.11 Eli Lilly and Company
11.11.1 Eli Lilly and Company Company Details
11.11.2 Eli Lilly and Company Business Overview
11.11.3 Eli Lilly and Company Hearing Loss Therapy Introduction
11.11.4 Eli Lilly and Company Revenue in Hearing Loss Therapy Business (2016-2021)
11.11.5 Eli Lilly and Company Recent Development
11.12 Novartis
11.12.1 Novartis Company Details
11.12.2 Novartis Business Overview
11.12.3 Novartis Hearing Loss Therapy Introduction
11.12.4 Novartis Revenue in Hearing Loss Therapy Business (2016-2021)
11.12.5 Novartis Recent Development
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Company Details
11.13.2 GlaxoSmithKline Business Overview
11.13.3 GlaxoSmithKline Hearing Loss Therapy Introduction
11.13.4 GlaxoSmithKline Revenue in Hearing Loss Therapy Business (2016-2021)
11.13.5 GlaxoSmithKline Recent Development
11.14 Teva pharmaceuticals
11.14.1 Teva pharmaceuticals Company Details
11.14.2 Teva pharmaceuticals Business Overview
11.14.3 Teva pharmaceuticals Hearing Loss Therapy Introduction
11.14.4 Teva pharmaceuticals Revenue in Hearing Loss Therapy Business (2016-2021)
11.14.5 Teva pharmaceuticals Recent Development
11.15 Audina Hearing Instruments
11.15.1 Audina Hearing Instruments Company Details
11.15.2 Audina Hearing Instruments Business Overview
11.15.3 Audina Hearing Instruments Hearing Loss Therapy Introduction
11.15.4 Audina Hearing Instruments Revenue in Hearing Loss Therapy Business (2016-2021)
11.15.5 Audina Hearing Instruments Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Hearing Loss Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of External and Middle Ear Devices
Table 3. Key Players of Bone-Anchored Hearing Aids
Table 4. Key Players of Cochlear Implants and Hybrids
Table 5. Key Players of Auditory Brainstem Implants
Table 6. Key Players of Others
Table 7. Global Hearing Loss Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Hearing Loss Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Hearing Loss Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Hearing Loss Therapy Market Share by Regions (2016-2021)
Table 11. Global Hearing Loss Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Hearing Loss Therapy Market Share by Regions (2022-2027)
Table 13. Hearing Loss Therapy Market Trends
Table 14. Hearing Loss Therapy Market Drivers
Table 15. Hearing Loss Therapy Market Challenges
Table 16. Hearing Loss Therapy Market Restraints
Table 17. Global Hearing Loss Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Hearing Loss Therapy Market Share by Players (2016-2021)
Table 19. Global Top Hearing Loss Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hearing Loss Therapy as of 2020)
Table 20. Ranking of Global Top Hearing Loss Therapy Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Hearing Loss Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hearing Loss Therapy Product Solution and Service
Table 24. Date of Enter into Hearing Loss Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hearing Loss Therapy Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Hearing Loss Therapy Revenue Market Share by Type (2016-2021)
Table 28. Global Hearing Loss Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Hearing Loss Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Hearing Loss Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Hearing Loss Therapy Revenue Market Share by Application (2016-2021)
Table 32. Global Hearing Loss Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Hearing Loss Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Hearing Loss Therapy Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Hearing Loss Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Hearing Loss Therapy Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Hearing Loss Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Hearing Loss Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Hearing Loss Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Hearing Loss Therapy Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Hearing Loss Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Hearing Loss Therapy Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Hearing Loss Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Hearing Loss Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Hearing Loss Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hearing Loss Therapy Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hearing Loss Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hearing Loss Therapy Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Hearing Loss Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Hearing Loss Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Hearing Loss Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Hearing Loss Therapy Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Hearing Loss Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Hearing Loss Therapy Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Hearing Loss Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Hearing Loss Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Hearing Loss Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hearing Loss Therapy Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hearing Loss Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hearing Loss Therapy Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Hearing Loss Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Hearing Loss Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Hearing Loss Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 64. Widex Company Details
Table 65. Widex Business Overview
Table 66. Widex Hearing Loss Therapy Product
Table 67. Widex Revenue in Hearing Loss Therapy Business (2016-2021) & (US$ Million)
Table 68. Widex Recent Development
Table 69. MED-EL Company Details
Table 70. MED-EL Business Overview
Table 71. MED-EL Hearing Loss Therapy Product
Table 72. MED-EL Revenue in Hearing Loss Therapy Business (2016-2021) & (US$ Million)
Table 73. MED-EL Recent Development
Table 74. Cochlear Company Details
Table 75. Cochlear Business Overview
Table 76. Cochlear Hearing Loss Therapy Product
Table 77. Cochlear Revenue in Hearing Loss Therapy Business (2016-2021) & (US$ Million)
Table 78. Cochlear Recent Development
Table 79. Smith & Nephew Company Details
Table 80. Smith & Nephew Business Overview
Table 81. Smith & Nephew Hearing Loss Therapy Product
Table 82. Smith & Nephew Revenue in Hearing Loss Therapy Business (2016-2021) & (US$ Million)
Table 83. Smith & Nephew Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Hearing Loss Therapy Product
Table 87. Pfizer Revenue in Hearing Loss Therapy Business (2016-2021) & (US$ Million)
Table 88. Pfizer Recent Development
Table 89. Bristol-Myers Squibb Company Company Details
Table 90. Bristol-Myers Squibb Company Business Overview
Table 91. Bristol-Myers Squibb Company Hearing Loss Therapy Product
Table 92. Bristol-Myers Squibb Company Revenue in Hearing Loss Therapy Business (2016-2021) & (US$ Million)
Table 93. Bristol-Myers Squibb Company Recent Development
Table 94. Allergan Company Details
Table 95. Allergan Business Overview
Table 96. Allergan Hearing Loss Therapy Product
Table 97. Allergan Revenue in Hearing Loss Therapy Business (2016-2021) & (US$ Million)
Table 98. Allergan Recent Development
Table 99. Renate pharmaceutical Company Details
Table 100. Renate pharmaceutical Business Overview
Table 101. Renate pharmaceutical Revenue in Hearing Loss Therapy Business (2016-2021) & (US$ Million)
Table 102. Renate pharmaceutical Recent Development
Table 103. Merck Company Details
Table 104. Merck Business Overview
Table 105. Merck Hearing Loss Therapy Product
Table 106. Merck Revenue in Hearing Loss Therapy Business (2016-2021) & (US$ Million)
Table 107. Merck Recent Development
Table 108. F. Hoffmann-La Roche Company Details
Table 109. F. Hoffmann-La Roche Business Overview
Table 110. F. Hoffmann-La Roche Hearing Loss Therapy Product
Table 111. F. Hoffmann-La Roche Revenue in Hearing Loss Therapy Business (2016-2021) & (US$ Million)
Table 112. F. Hoffmann-La Roche Recent Development
Table 113. Eli Lilly and Company Company Details
Table 114. Eli Lilly and Company Business Overview
Table 115. Eli Lilly and Company Hearing Loss Therapy Product
Table 116. Eli Lilly and Company Revenue in Hearing Loss Therapy Business (2016-2021) & (US$ Million)
Table 117. Eli Lilly and Company Recent Development
Table 118. Novartis Company Details
Table 119. Novartis Business Overview
Table 120. Novartis Hearing Loss Therapy Product
Table 121. Novartis Revenue in Hearing Loss Therapy Business (2016-2021) & (US$ Million)
Table 122. Novartis Recent Development
Table 123. GlaxoSmithKline Company Details
Table 124. GlaxoSmithKline Business Overview
Table 125. GlaxoSmithKline Hearing Loss Therapy Product
Table 126. GlaxoSmithKline Revenue in Hearing Loss Therapy Business (2016-2021) & (US$ Million)
Table 127. GlaxoSmithKline Recent Development
Table 128. Teva pharmaceuticals Company Details
Table 129. Teva pharmaceuticals Business Overview
Table 130. Teva pharmaceuticals Hearing Loss Therapy Product
Table 131. Teva pharmaceuticals Revenue in Hearing Loss Therapy Business (2016-2021) & (US$ Million)
Table 132. Teva pharmaceuticals Recent Development
Table 133. Audina Hearing Instruments Company Details
Table 134. Audina Hearing Instruments Business Overview
Table 135. Audina Hearing Instruments Hearing Loss Therapy Product
Table 136. Audina Hearing Instruments Revenue in Hearing Loss Therapy Business (2016-2021) & (US$ Million)
Table 137. Audina Hearing Instruments Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hearing Loss Therapy Market Share by Type: 2020 VS 2027
Figure 2. External and Middle Ear Devices Features
Figure 3. Bone-Anchored Hearing Aids Features
Figure 4. Cochlear Implants and Hybrids Features
Figure 5. Auditory Brainstem Implants Features
Figure 6. Others Features
Figure 7. Global Hearing Loss Therapy Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Otology Clinics Case Studies
Figure 10. Ambulatory Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Hearing Loss Therapy Report Years Considered
Figure 13. Global Hearing Loss Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Hearing Loss Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Hearing Loss Therapy Market Share by Regions: 2020 VS 2027
Figure 16. Global Hearing Loss Therapy Market Share by Regions (2022-2027)
Figure 17. Global Hearing Loss Therapy Market Share by Players in 2020
Figure 18. Global Top Hearing Loss Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hearing Loss Therapy as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Hearing Loss Therapy Revenue in 2020
Figure 20. Global Hearing Loss Therapy Revenue Market Share by Type (2016-2021)
Figure 21. Global Hearing Loss Therapy Revenue Market Share by Type (2022-2027)
Figure 22. North America Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Hearing Loss Therapy Market Share by Type (2016-2027)
Figure 24. North America Hearing Loss Therapy Market Share by Application (2016-2027)
Figure 25. North America Hearing Loss Therapy Market Share by Country (2016-2027)
Figure 26. United States Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Hearing Loss Therapy Market Share by Type (2016-2027)
Figure 30. Europe Hearing Loss Therapy Market Share by Application (2016-2027)
Figure 31. Europe Hearing Loss Therapy Market Share by Country (2016-2027)
Figure 32. Germany Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Hearing Loss Therapy Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Hearing Loss Therapy Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Hearing Loss Therapy Market Share by Region (2016-2027)
Figure 42. China Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Hearing Loss Therapy Market Share by Type (2016-2027)
Figure 50. Latin America Hearing Loss Therapy Market Share by Application (2016-2027)
Figure 51. Latin America Hearing Loss Therapy Market Share by Country (2016-2027)
Figure 52. Mexico Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Hearing Loss Therapy Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Hearing Loss Therapy Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Hearing Loss Therapy Market Share by Country (2016-2027)
Figure 58. Turkey Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Hearing Loss Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Widex Revenue Growth Rate in Hearing Loss Therapy Business (2016-2021)
Figure 62. MED-EL Revenue Growth Rate in Hearing Loss Therapy Business (2016-2021)
Figure 63. Cochlear Revenue Growth Rate in Hearing Loss Therapy Business (2016-2021)
Figure 64. Smith & Nephew Revenue Growth Rate in Hearing Loss Therapy Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Hearing Loss Therapy Business (2016-2021)
Figure 66. Bristol-Myers Squibb Company Revenue Growth Rate in Hearing Loss Therapy Business (2016-2021)
Figure 67. Allergan Revenue Growth Rate in Hearing Loss Therapy Business (2016-2021)
Figure 68. Renate pharmaceutical Revenue Growth Rate in Hearing Loss Therapy Business (2016-2021)
Figure 69. Merck Revenue Growth Rate in Hearing Loss Therapy Business (2016-2021)
Figure 70. F. Hoffmann-La Roche Revenue Growth Rate in Hearing Loss Therapy Business (2016-2021)
Figure 71. Eli Lilly and Company Revenue Growth Rate in Hearing Loss Therapy Business (2016-2021)
Figure 72. Novartis Revenue Growth Rate in Hearing Loss Therapy Business (2016-2021)
Figure 73. GlaxoSmithKline Revenue Growth Rate in Hearing Loss Therapy Business (2016-2021)
Figure 74. Teva pharmaceuticals Revenue Growth Rate in Hearing Loss Therapy Business (2016-2021)
Figure 75. Audina Hearing Instruments Revenue Growth Rate in Hearing Loss Therapy Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
難聴セラピーのグローバル市場：規模・現状・予測2019-2025 Hearing loss therapy refers to the latest technological advances and treatment options for people with hearing impairment, including external and middle ear devices, bone anchors, cochlear implants and mixed arteries, auditory brainstem implants, and the transfer of genes to the inner ear through st…- 難聴セラピーのグローバル市場：規模・現状・予測2019-2025 Hearing loss therapy refers to the latest technological advances and treatment options for people with hearing impairment, including external and middle ear devices, bone anchors, cochlear implants and mixed arteries, auditory brainstem implants, and the transfer of genes to the inner ear through st…
- 聴覚インプラント及びバイオマテリアルのグローバル市場調査 2019年 The global Hearing Implants and Biomaterials market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hearing Implants and Biomaterials volume and value at global level, regional level and company level. Fro…
- 世界の骨伝導聴覚インプラント産業調査2019-2025 Bone conductive hearing implants are surgical implantable devices based on bone conduction mechanism. This device is used in the treatment of certain types of hearing loss such as chronic ear infections, malformations of outer or middle ear, single-sided deafness, acoustic neuroma, cholesteatoma, an…
- 世界の骨伝導聴覚インプラント産業調査2019-2025 Bone conductive hearing implants are surgical implantable devices based on bone conduction mechanism. This device is used in the treatment of certain types of hearing loss such as chronic ear infections, malformations of outer or middle ear, single-sided deafness, acoustic neuroma, cholesteatoma, an…